In particular, GC cell lines demonstrating FGFR2 amplification (KATO-III, OCUM-2M, SNU-16, and HSC-39) resulted in significant reductions in cell survival, with IC50 values ranging from 0.1 to 2.0 mol/L. This evidence concerns the gene FGFR2 and gastric cancer.